Related references
Note: Only part of the references are listed.US Renal Data System 2021 Annual Data Report: Epidemiology of Kidney Disease in the United States
Kirsten L. Johansen et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2022)
OPTN/SRTR 2020 Annual Data Report: Kidney
K. L. Lentine et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2022)
KDIGO 2021 CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF GLOMERULAR DISEASES
Brad H. Rovin et al.
KIDNEY INTERNATIONAL (2021)
Systemic immunity in cancer
Kamir J. Hiam-Galvez et al.
NATURE REVIEWS CANCER (2021)
Malignancies in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis: A Population-based Cohort Study
Caroline Heijl et al.
JOURNAL OF RHEUMATOLOGY (2020)
Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Rituximab: Analyses of Global Postmarketing Safety Data and Long-Term Clinical Trial Data
Paul Emery et al.
RHEUMATOLOGY AND THERAPY (2020)
The population-level costs of immunosuppression medications for the treatment of glomerulonephritis are increasing over time due to changing patterns of practice
Sean Barbour et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Malignancy in Renal Transplant Recipients Exposed to Cyclophosphamide Prior to Transplantation for the Treatment of Native Glomerular Disease
Margaret R. Jorgenson et al.
PHARMACOTHERAPY (2018)
Post-Transplantation Lymphoproliferative Disorders in Adults
Daan Dierickx et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Effect of rituximab on malignancy risk in patients with ANCA-associated vasculitis
Emma E. van Daalen et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis
JulieAnne G. McGregor et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Cost-effective treatment modalities for reducing morbidity associated with chronic kidney disease
Thomas W. Ferguson et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2015)
Sirolimus effects on cancer incidence after kidney transplantation: a meta-analysis
Elizabeth L. Yanik et al.
CANCER MEDICINE (2015)
5 Immune system: a double-edged sword in cancer
Bodduluru Lakshmi Narendra et al.
INFLAMMATION RESEARCH (2013)
Effect of Immunosuppression for Primary Renal Disease on the Risk of Cancer in Subsequent Renal Transplantation: A Population-Based Retrospective Cohort Study
Adrian D. Hibberd et al.
TRANSPLANTATION (2013)
Alemtuzumab Induction in Renal Transplantation
Michael J. Hanaway et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Hematologic Malignant neoplasms after drug exposure in rheumatoid arthritis
Sasha Bernatsky et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Cancer incidence among Canadian kidney transplant recipients
P. J. Villeneuve et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Cancer incidence before and after kidney transplantation
Claire M. Vajdic et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Viral infection in the renal transplant recipient
CN Kotton et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Lymphomas after solid organ transplantation:: A collaborative transplant study report
G Opelz et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients
RT Bustami et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: A prospective study in Queensland, Australia
RP Carroll et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Share Paper
